Identificador persistente para citar o vincular este elemento:
https://accedacris.ulpgc.es/handle/10553/139828
Campo DC | Valor | idioma |
---|---|---|
dc.contributor.author | Bance, M. | en_US |
dc.contributor.author | Lustig, L. | en_US |
dc.contributor.author | Ishiyama, A. | en_US |
dc.contributor.author | Nash, R. | en_US |
dc.contributor.author | Polo, R. | en_US |
dc.contributor.author | Ramos De Miguel, Ángel | en_US |
dc.contributor.author | Manrique, M. J. | en_US |
dc.contributor.author | Rubinstein, J. T. | en_US |
dc.contributor.author | Landry, E. | en_US |
dc.contributor.author | Runge, C. | en_US |
dc.contributor.author | Quigley, T. | en_US |
dc.contributor.author | Riggs, J. | en_US |
dc.contributor.author | Corrales, E. | en_US |
dc.contributor.author | Whitton, J. | en_US |
dc.contributor.author | Anderson, J. | en_US |
dc.contributor.author | Valayannopoulos, V. | en_US |
dc.date.accessioned | 2025-06-10T12:23:52Z | - |
dc.date.available | 2025-06-10T12:23:52Z | - |
dc.date.issued | 2025 | en_US |
dc.identifier.issn | 1043-0342 | en_US |
dc.identifier.other | WoS | - |
dc.identifier.uri | https://accedacris.ulpgc.es/handle/10553/139828 | - |
dc.description.abstract | Otoferlin is critical for inner hair cell (IHC) signal transmission to auditory nerve fibers. Biallelic otoferlin gene (OTOF) variants typically cause severe-to-profound deafness. As per preclinical data, DB-OTO gene therapy promotes IHC-selective otoferlin expression from the human OTOF gene, which may instate high-quality hearing. In this first-in-human multicenter, phase 1/2 open-label clinical trial with DB-OTO (CHORD, NCT05788536), safety, tolerability and preliminary efficacy of DB-OTO is evaluated in pediatric patients with profound OTOF-related deafness. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Human Gene Therapy | en_US |
dc.source | Human Gene Therapy [ISSN 1043-0342],v. 36 (3-4), p. E136, Abstract OR016, (Febrero 2025) | en_US |
dc.subject | 320507 Neurología | en_US |
dc.title | Preliminary safety and efficacy of DB-OTO gene therapy in pediatric patients with profound deafness due to otoferlin variants: The CHORD phase 1/2 open-label trial | en_US |
dc.type | info:eu-repo/semantics/conferenceObject | en_US |
dc.type | ConferenceObject | en_US |
dc.relation.conference | ESGCT 31st Annual Congress In collaboration with SITGEC Rome, Italy October 22-25, 2024 Online Only | en_US |
dc.identifier.isi | 001418811501016 | - |
dc.identifier.eissn | 1557-7422 | - |
dc.description.lastpage | E136 | en_US |
dc.identifier.issue | 3-4 | - |
dc.description.firstpage | E136 | en_US |
dc.relation.volume | 36 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Actas de congresos | en_US |
dc.contributor.daisngid | 19564780 | - |
dc.contributor.daisngid | 25602827 | - |
dc.contributor.daisngid | 9385194 | - |
dc.contributor.daisngid | 26820450 | - |
dc.contributor.daisngid | 71252153 | - |
dc.contributor.daisngid | 74837913 | - |
dc.contributor.daisngid | 74269492 | - |
dc.contributor.daisngid | 13857597 | - |
dc.contributor.daisngid | 68832311 | - |
dc.contributor.daisngid | 54896241 | - |
dc.contributor.daisngid | 45308696 | - |
dc.contributor.daisngid | 53704999 | - |
dc.contributor.daisngid | 50786092 | - |
dc.contributor.daisngid | 4900948 | - |
dc.contributor.daisngid | 74861815 | - |
dc.contributor.daisngid | 30426419 | - |
dc.description.numberofpages | 1 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:Bance, M | - |
dc.contributor.wosstandard | WOS:Lustig, L | - |
dc.contributor.wosstandard | WOS:Ishiyama, A | - |
dc.contributor.wosstandard | WOS:Nash, R | - |
dc.contributor.wosstandard | WOS:Polo, R | - |
dc.contributor.wosstandard | WOS:Ramos, A | - |
dc.contributor.wosstandard | WOS:Manrique, MJ | - |
dc.contributor.wosstandard | WOS:Rubinstein, JT | - |
dc.contributor.wosstandard | WOS:Landry, E | - |
dc.contributor.wosstandard | WOS:Runge, C | - |
dc.contributor.wosstandard | WOS:Quigley, T | - |
dc.contributor.wosstandard | WOS:Riggs, J | - |
dc.contributor.wosstandard | WOS:Corrales, E | - |
dc.contributor.wosstandard | WOS:Whitton, J | - |
dc.contributor.wosstandard | WOS:Anderson, J | - |
dc.contributor.wosstandard | WOS:Valayannopoulos, V | - |
dc.date.coverdate | Febrero 2025 | en_US |
dc.identifier.abstractid | OR016 | - |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.sjr | 1,091 | |
dc.description.jcr | 4,1 | |
dc.description.sjrq | Q2 | |
dc.description.jcrq | Q1 | |
dc.description.scie | SCIE | |
dc.description.miaricds | 11,0 | |
item.grantfulltext | open | - |
item.fulltext | Con texto completo | - |
crisitem.author.dept | GIR SIANI: Modelización y Simulación Computacional | - |
crisitem.author.dept | IU Sistemas Inteligentes y Aplicaciones Numéricas | - |
crisitem.author.dept | Departamento de Informática y Sistemas | - |
crisitem.author.orcid | 0000-0002-0528-815X | - |
crisitem.author.parentorg | IU Sistemas Inteligentes y Aplicaciones Numéricas | - |
crisitem.author.fullName | Ramos De Miguel, Ángel | - |
Colección: | Actas de congresos |
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.